Monday, 8 April 2019

Surgical Equipment Market to Observe Strong Development by 2018

Market Scenario
Surgical equipment have wide applications in distinctive surgical techniques, for example, neurosurgery, plastic and reconstructive surgeries, wound closure, urology, obstetrics and gynaecology, thoracic surgery, micro-vascular, cardiovascular, orthopaedic surgery, laparoscopy and others. The market is driven by increasing number of surgeries, & hospitals, increasing prevalence of different diseases and increasing geriatric population have boosted the market growth. Moreover, technological advancement, increasing number of ambulatory services and government initiatives have a synergistic effect on the market. However, high cost of the devices, shortage of skilled labour and strict regulatory policies are the major restraints for the market
The global surgical equipment market is driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, obesity, skin diseases, increasing number of surgeries in ambulatory surgical centers and hospitals, and rising geriatric population. Additionally, the growth of the medical device market, increasing number of surgical centers, and government initiatives have a synergistic effect on the market. However, the growth of the market is restrained by various factors such as high cost of surgical devices and strict regulatory policies for various regulatory authorities.
The global surgical equipment market is expected to grow at a CAGR of 6.2% during the forecast period.
Latest Industry News
  • Surgical services at the Georgetown Public Hospital have received a donation of medical equipment and supplies from the government of China. 28 DEC 2018
  • AppOrtho is utilizing the High Country’s first robot-assisted surgery system to aid with knee replacement surgeries. 3 JAN 2019
Key Players
The key players in the global surgical equipment market include B. Braun Melsungen AG (Germany), CONMED Corporation (USA), COVIDIEN (USA), Erbe Elektromedizin GmbH (Germany), Ethicon USA, LLC. (USA), Integra LifeSciences Corporation (USA), KARL STORZ & Co. (USA), KLS Martin (Germany) MEDICON (USA), Smith & Nephew (UK), and Stryker Corporation (USA).
Segmentation
The global surgical equipment market is divided into product type, application, and end-user.
On the basis of product type, the market is segmented into surgical sutures and staplers, handheld instruments, electrosurgical devices, electrosurgical generators, monitoring devices, and others. Surgical sutures and staplers are further segmented into absorbable and non-absorbable sutures. Handheld instruments are sub-segmented into forceps, sutures, visual scope, and others. Electrosurgical devices are further categorized into electrosurgical instruments such as HET bipolar system, electrosurgical pencils, smoke evacuation system, electrosurgical generators, and others.
On the basis of application, the market is segmented into neurosurgery, wound closure, urology, cardiovascular surgeries, orthopedic surgery, and others.
On the basis of end-user, the market is segmented into hospitals, ambulatory surgical centers, and others.
Regional Analysis
Americas holds the largest share of the surgical equipment market. The growth of the medical device sector, increasing emphasis on quality care, and the availability of technologically-advanced surgical devices are the major drivers for the growth of the market. North America holds the largest share, with the U.S. being the largest contributor to the growth of the market. In the U.S., the presence of key players in the medical device industry and extensive use of surgical devices drive the market. South America also exhibits tremendous growth opportunities with an increase in the demand for surgical devices. The Agency for Healthcare Research and Quality reported that nearly 11 million and 10 million invasive and therapeutic surgeries were carried out in ambulatory and inpatient settings, respectively, in the U.S. in 2014.
Europe, Germany, the U.K., and France are the major contributors to the growth of the market. The increasing number of market players manufacturing surgical equipment, growing government support, and increase in outpatient surgeries drive the market in the European nations. Additionally, increasing healthcare spending by European nations such as the U.K. and Germany also contributes to the growth of the market.
The Asia Pacific, surgical equipment market, is driven by the huge demand for surgical devices and instruments, increasing awareness about quality care in hospitals and surgical centers, and the ever-increasing prevalence of chronic diseases such as cardiovascular diseases. India and Australia exhibit the fastest growth in the market owing to the availability of qualified and skilled medical professionals and growing healthcare expenditure.
In the Middle East and Africa, the market growth is attributed to the increasing availability of specialty care services in countries such as the United Arab Emirates and Saudi Arabia. Africa exhibits a steady growth with the demand for primary care services in the region.
Browse Complete 130 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/surgical-equipment-market-556


About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels:

Leukemia Therapeutics Market 2018 Analysis, Opportunities and Forecast to 2023

Leukemia is blood cancer which most commonly in adults and children. Acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia are the major types of the leukemia. Leukemia therapeutics are used in treating the leukemia.
The globalleukemia therapeutics anticipated to have held a market value of USD 10.7 billion in the year 2017 and is expected to grow at a CAGR of 5.3% during the forecast period.
Segmentation
The global leukemia therapeutics market has been segmented into type, applications, and region.
Based on type, leukemia therapeutics market is segmented into chemotherapy, biological therapy, targeted therapy, radiation therapy, and stem cell transplant. The chemotherapy segment is expected to account for the largest share segment of the market in 2017. Chemotherapy segment further sub segmented into alkylating agents, antimetabolites, antitumor antibiotics, and others.
Based on applications, leukemia therapeutics market is segmented into acute lymphocytic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia, and others. The acute lymphocytic leukemia segment is expected to account for the largest share segment of the market in 2017.
Regional Market Summary
Geographically, the Americas is anticipated to dominate the global leukemia therapeutics market owing to a well-established player, innovative therapies to drive the market for leukemia, increase prevalence of leukemia, and increasing older population.
Europe is expected to hold the second largest position in the global leukemia therapeutics market. The market growth in this region is attributed to increase prevalence of leukemia.
The leukemia therapeutics market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region.
The Middle East & Africa has the least share of the leukemia therapeutics market.
Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/leukemia-therapeutics-market-7425


About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Cardiac Valve Market - Granular Market Report and Review, 2018

Market scenario
The global cardiac valve market is expected to grow at a CAGR of 11.5% during the forecasted period.
Increasing number of people with cardiovascular diseases and increasing number of cardiac surgery have stimulated the growth of the market. Additionally, increasing incident of diabetes and obesity, adoption of deskbound lifestyle rising geriatric population, and excessive use of tobacco and alcohol projected to propel the growth of the market.
Cardiac valve or heart valve allows blood to flow in only one direction through the heart. Human heart consists of four valves. These valves open and closes compulsory on differential blood pressure on each side.
On the other hand, high cost of treatment methods may hamper the growth of the global cardiac valve market over the forecast period.
Segmentation
The global cardiac valve market is segmented on the basis of types, by diseases, by treatment, and by end users.

On the basis of types, the market is segmented into trans-catheter heart valve, tissue heart valve, mechanical heart valve, and others.
On the basis of disease, the market is segmented into aortic valve replacement, heart valve disease, mitral valve stenosis, and others.
On the basis of treatments, it is segmented into valve replacement, valve repair, and others.
On the basis of end users the market is segmented into cardiac research institute, hospital & clinics, and others.
Key players
  • Medtronic,
  • Edwards Lifesciences Corporation (U.S.),
  • Boston Scientific Corporation (U.S.),
  • Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), 
  • LivaNova PLC (U.K.),
  • Symetis SA (Switzerland),
  • Jenavalve Technology, Inc. (Germany),
  • CryoLife, Inc. (U.S.),
  • TTK HealthCare (India),
  • Colibri Heart Valve, LLC (U.S.),
  • Lepu Medical Technology Co., Ltd. (China),
  • Braile Biomédica (Brazil)

Regional analysis
The Americas mainly include North America and South America of which North America dominates the market owing to the presence of huge number of patient with cardiac diseases, increasing geriatric population, and increasing healthcare expenditure.  
In Asia Pacific, increasing government support for research & development in healthcare domain, growing number of cardiovascular diseases drive the growth of the market in this region.
Europe is the second highest revenue generating region in the cardiac valve market. Europe is mainly consist of Eastern Europe and Western Europe. More developed countries of Western Europe such as Germany, France, and the UK are holding the major market share, whereas the East European countries are also growing at a significant rate. Moreover, owing to developing healthcare infrastructure and increasing healthcare expenditure will boost the market growth in this region.
The Middle East & Africa is expected to show a least market share due to less availability of medical facilities, and less development in healthcare domain
Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/cardiac-valve-market-560

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels:

Friday, 5 April 2019

Breast Biopsy Market 2018 Analysis, Opportunities and Forecast to 2023

The prevalence of breast cancer has led to an increased level of reliance on breast biopsy procedures. Improved screening campaigns are also increasing the need for breast biopsy procedures. Furthermore, the rise in the awareness regarding cancer is anticipated to further motivate the expansion of the breast biopsy market in the forecast period.
Increased cancer detection rates globally have contributed to a rise in biopsy procedures. Market reports connected with the healthcare industry have been presented by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better. The market is projected to develop at a favorable CAGR rate in the forecast period.
Competitive Landscape
Significant reductions in administrative costs are inducing further expansion of the market. The vertical additions and product tactics of the market are boosting the potential of the market players. The development of a robust value chain is further motivating the development of the market. The strategic goals intended for the market are reinforced due to favorable product differentiation carried out by market competitors. The growth of the market is moving in a favorable direction due to new product launches or rising gross revenue of the players in the market. Increased adaptability of market players to new market trends and customers inclinations are lifting the growth curve of the market and will continue do so in the forecast period. The successful implementation of strategies is expected to motivate the market in the coming years.
The main players in the breast biopsy market globally are C.R. Bard Inc., NuVue Therapeutics, Argon Medical Devices, Inc., Devicor Medical Products Inc. Hologic Inc. Argon Medical Devices, Cook Medical Incorporated, Leica Biosystems, Encapsule Medical Devices LLC., Johnson & Johnson, Intact Medical Corporation, Becton, Dickinson and Company, Conceptus INC, Hologic Inc., Galini SRL, Karl Storz GmbH & Co. Kg, GE Healthcare.
Segmentation
The breast biopsy market has been carried out on the basis of guidance technology, technique type, product, and end-user. Based on product, the breast biopsy market has been segmented into biopsy tables, guidance systems, biopsy needles, biopsy wires, and others. The segmentation on the basis of technique type, the market is segmented into core needle biopsy, biopsy markers, fine needle aspiration biopsy, surgical biopsy, MRI-guided core needle biopsy, wire localization, and sentinel node biopsy. Additionally, the core needle biopsy segment is segmented into vacuum-assisted biopsy, ultrasound-guided core biopsy, stereotactic core needle biopsy, and freehand core-needle biopsy. The surgical biopsy is divided into excisional biopsy and incisional biopsy. Based on guidance technology, the breast biopsy market is segmented into mammography-guided magnetic resonance, CT-guided biopsy, ultrasound-guided, and other image-guided breast biopsy (thermography and PET). The end-user based segmentation of the market consists of ambulatory surgical centers, hospitals, diagnostic centers, among others. The regions that are a part of the breast biopsy market are Europe, Asia Pacific, Americas, and the Middle East and Africa.
Detailed Regional Analysis
The regional analysis of the breast biopsy market observes that the North American region is projected to account for the principal market share owing to the early implementation of sophisticated medical technologies and constant development by companies working in cancer diagnostics. The breast biopsy market is mainly focused on the North American and European regions, which is expected to account for more than 50% of the market portion. The European market is estimated to hold the next biggest market share as breast cancer is found to be most common in countries such as the UK and Belgium. The market share in the Asia Pacific region is also estimated to experience growth in the near future due to access to optimal treatment facilities, better adoption rate, growing demand for advanced technology, growing government initiatives, and rising healthcare costs. The market in the Middle Eastern and African region is projected to be responsible for the smallest share of the breast biopsy market owing to deficiency of technical knowledge, an underdeveloped healthcare sector, and meager medical facilities.
Browse Complete 100 Pages Premium Research Report Enabled with 90 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/breast-biopsy-market-6288

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Electronic Pill Market to Observe Strong Development by 2018

Market Scenario
The growing prevalence of gastrointestinal diseases, increasing unhealthy food consumption, increase in research and development activities, growing government reimbursement policies, rising geriatric population, increased need for rapid diagnostics, and adoption of advanced technologies are the key factors for the electronic pill market to grow. However, factors such as bowel obstruction, lack of awareness, capsule retention and high costs are expected to restrict the market growth during the forecast period.
The Global Electronic Pill Market is expected to reach an approximate CAGR of 15% during the forecast period.
The electronic pill is an ingestible capsule that is embedded with sensors and camera. After ingesting the pill, the pill captures several images per second of the gastrointestinal tract which is received by the connected recording device. It is a monitoring system used to monitor temperature, pH, conductivity and dissolved oxygen. Electronic Pills are used for diagnostics of various gastrointestinal tract diseases like colon cancer, colon polyps, gastrointestinal bleeding and other infectious diseases. The increase in preference of non-invasive methods for diagnostics is driving the growth of the market. Moreover, the rising geriatric population, increasing prevalence of gastrointestinal diseases like colorectal cancer, changing lifestyle, increasing unhealthy eating habits, controlled drug delivery and better way of endoscopy procedures are major factors influencing the growth of the market.
Global Electronic Pill Market, by Key Players
  • CapsoVision, Inc. (US)
  • Given Imaging Ltd. (Israel)
  • Medimetrics (Mexico)
  • Bio-Images Drug Delivery BDD LTD (UK)
  • Proteus Digital Health (US)
  • Olympus Corporation
  • Medtronic
  • Medisafe
  • JINSHAN Science & Technology
  • INTROMEDIC
Segmentation
On the basis of region, the global Electronic Pill market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the U.K., Spain, and the rest of Western Europe. The Asia Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
The global electronic pill market is segmented on the basis of Application, Target area, Parts and end user. The electronic pill market, by application, is sub-segmented into Capsule Endoscopy, Drug Delivery, and Patient Monitoring. Target area category includes Oesophagus, Stomach, Small Intestine, and large intestine.
By parts, the market is categorized into biocompatible capsule encasing microsensors, Control chip, Radio transmitter and Power source. On the basis of end-user, the market is segmented into Hospitals, Diagnostic centers, Clinical Research Organizations and Medical Centers.
Regional Market Summary
The Electronic Pill market is dominated by North America owing to rising prevalence of gastrointestinal disorders and high R&D investments within this region stimulate market growth. According to the US Investments in Medical and Health Research and Development in 2016, the United States invested total $171.8 billion in medical and health R&D and the investment increased by 20.6% from 2013 to 2016. Also, the rising adoption of technologically advanced systems for early diagnosis of gastrointestinal disorders influences the market growth in this region.
It is estimated that Europe stood second in the global Electronic Pill market. The increasing prevalence of gastric cancer is driving the growth of this market in Europe. According to the Cancer Research UK in 2015, 6740 new cases of stomach cancer in the U.K and is among the most common prevalent cancer. Thus, increasing prevalence of gastric cancer in Europe drives the market growth. Furthermore, the rapidly growing healthcare sector in Europe is expected to boost the market in this region.
Asia Pacific was projected to be the fastest growing region for the global Electronic Pill market. Key factors such as rising geriatric population, growing patient pool, high incidence of gastrointestinal diseases and developing healthcare infrastructure drive the market in this region. According to the Asian Development Bank (ADB), the geriatric population in Asia is expected to reach 923 million by 2050. This provides favorable backgrounds for the market to grow.
The Middle East and Africa holds the least share in the global Electronic Pill market due to the presence of stringent government policies and poor economic growth. However, growing awareness and increasing investment by private market players in this region can boost the market growth. 
Browse Complete 100 Pages Premium Research Report Enabled with 95 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/electronic-pill-market-6204

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Insect Protein Market size and Key Trends in terms of volume and value 2018

Market Scenario:
The Global Insect Protein Market is expected to reach an approximate CAGR of 16.5% during the forecast period. The ever-rising population eventually leading to decrease in agricultural lands is likely to drive the market. According to the United Nations in 2017, the world population was 7.6 billion and is expected to reach 9.8 billion by 2050. Moreover, in 2015, the U.S. Census Bureau projected that the U.S. population would reach 417 million by 2060 that is a 38% increase as compared to 2007. The trend of protein-rich diet, the high cost of animal and plant-based proteins, and health awareness are other important factors influencing the growth of the market. For instance, house crickets contain 205 g/kg of protein on an average, whereas beef contains 256 g/kg. Similarly, mealworms contain unsaturated omega-3 and six fatty acids as much as fish and pork. With these benefits of insect proteins, the market is projected to grow rapidly.
However, factors such as stringent environmental regulations, risks associated (allergies) with insect consumption, psychological barriers, religious and cultural believes, and ethical issues are expected to hinder the market growth during the forecast period.
Global Insect Protein Market, by Key Players
  • Thailand Unique
  • Kreca Ento-Food
  • Nordic Insect Economy Ltd.
  • Entomo Farms Ltd.
  • Enviro Flight
  • Proti-Farm
  • Exo Inc.
  • Crik Nutrition
  • Deli Bugs Ltd.
  • Agriprotein Technologies
  • Bugsolutely
  • Hopper Foods
  • Hargol Food Tech
  • Griopro
  • Kric8
Segmentation
The global insect protein market is segmented on the basis of type, product type, application, and distribution channel. The insect protein market, by type, is segmented into crickets, mealworms, black soldier flies, grasshoppers, ants, silkworms, cicadas, and others. The product type segment is sub-segmented into whole insects, insect meals, insect powder, insect protein bars and protein shakes, insect baked products and snacks, insect confectionaries, insect beverages, insect oil, and others. The application segment is sub-segmented into human consumption, animal nutrition, and cosmetics and pharmaceutical. On the basis of distribution channel, the market is categorized into online portals and retail stores.
On the basis of region, the global insect protein market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas is sub-segmented into North America and South America. The North American region is further segmented into the U.S. and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the U.K., Spain, and the rest of Western Europe. The Asia Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Regional Market Summary
The insect protein market is dominated by Asia Pacific owing to the huge increasing population.
The Americas will witness growth for the insect protein market owing to growing awareness and increasing nutrition demand.  The increase in the per capita meat consumption and fears of protein shortage fuel the market within the region.
Asia is the most populous of all the continents and has two most populous countries, China and India. According to World Population Review in 2017, China has the largest population in the world which is estimated to be 1,377,124,512, which is 31.69% of Asia's total population and 18% of the world's population. China is followed by India with an estimated population of 1,285,800,000 and accounts for 29.36% of the continent's population. With the growth in population, the need for healthy food alternatives is also growing. Moreover, insect harvesting, gathering, and processing is an important occupation in some countries of Asia. This drives the growth of the market in this region.
Europe is expected to be the second largest region in the global insect protein market. The EU regulation 2017, granted permission to use insect proteins as fish feed, thus offering a milestone for the European insect production sector. The increased production of insect feed in Europe for the aquaculture sector drives the growth of the market in Europe. The aquaculture sector has grown tremendously and is an important contributor to the region’s food production sector. According to Eurostat in 2017, aquaculture accounted for 19.7% of the total fisheries production and the amounted for EUR 4 billion. Thus, rapidly growing aquaculture sector provides favorable backgrounds for the market to grow in Europe.
The Middle East holds the least share in the global insect protein market due to the presence of stringent government policies. On the other hand, Africa holds a large share in the Middle Eastern and African region for the insect protein market, as the tradition of insect consumption is more than hundreds of years old. The rising price of beef and meat and the tropical climate for insect growth in this region also pose a huge opportunity for the market to grow in this region.
Browse Complete 100 Pages Premium Research Report Enabled with 96 Respective Tables and Figures at @ https://www.marketresearchfuture.com/reports/insect-protein-market-6094

       
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Worldwide Spinal Needles Market 2018 Outlook, top 10 Industry players comprehensive analysis and Forecast to 2023

Spinal needles are medical devices generally used in administration of drug or diagnostic purposes. Spinal needles are inserted into the spinal cord or canal for the collecting cerebrospinal fluid (CSF) for diagnostic testing purposes or drug administration for the treatment of any neurological disease, fractures or vertebroplasty. Spinal anaesthesia is done to temporarily numb the area of pain during spine surgery in which the spinal needles play an important role in the drug administration of anaesthesia. The global spinal needle market is expected to grow at a CAGR of 6.8% during the forecasted period 2017-2023.
Key Players
The key players in the global spinal needles market include Argon Medical Devices Inc (Netherland),  B. Braun (Germany), BD (USA), Boston Scientific (USA), Cook Medical (USA), Exel International (USA), Halyard Health (USA), Medline Industries (USA), Medtronic (UK), MYCO Medical (USA), Novo Nordisk (Denmark), Sarstedt (UK), Smiths Medical (USA), Stryker Corporation (USA), and Wallach Surgical (USA).
Latest Industry News
  • Abacus Finance Group LLC has provided senior debt financing to support Zavation Medical Products LLC’s acquisition of Tampa, Florida-based Pan Medical US Corp, a maker of medical products used in minimally invasive procedures. 22 OCT 2018
  • Two University of Virginia alumni have built a new spine-finding device that is giving the practice of identifying the correct insertion point for epidurals and other forms of spinal anesthesia, a much-needed upgrade. 14 JUNE 2018
Regional analysis
The regional segmentation of the global spinal needles market segments the market into continent-based regional markets namely The Americas (North America & South America), Asia Pacific, Europe, and the Middle East & Africa (MEA). The biggest regional market is The Americas. North America alone holds the potential to be the largest market due to its strong economies are known as the United States of America (USA) and Canada. Many key market players are based in the USA. In this region, the availability of advanced medical facilities makes North America a bigger market than South America. Factors supporting the market growth in this region include increasing awareness among the people, an increasing number of spinal surgeries, and the increasing prevalence of different neurological disease.
Decent technological advancement, increasing healthcare expenditure, rising prevalence of diseases, and well-developed healthcare sectors are the reasons that have made Europe the second largest regional market after North America. Due to the reasons same as The Americas, Western Europe is a bigger market than Eastern Europe. The significant country-specific markets in this region are France, Italy, Germany, the United Kingdom (UK), and Spain, followed by the rest of Western Europe and then Eastern Europe.
According to the report, Asia Pacific region is likely to witness a faster growth for the market during the forecast period. Factors contributing to the faster growth include the presence of huge patient population suffering from different infectious diseases and steadily rising quality of medical services in countries like India and Japan. Apart from these two countries, the other country-specific markets are Australia, South Korea, and China, followed by the rest of the Asia Pacific region. 
The MEA region shows limited market slow and steady growth. The reasons for the slow market growth in this region are lack of awareness, lack of education, lack of technological development, political instability, poor healthcare facilities, and healthcare not considered a priority by most governments. The primal country-specific markets in this region are Kuwait, Oman, Qatar, United Arab Emirates (UAE), and Saudi Arabia, followed by the rest of the MEA region.
Intended Audience 
  • Spinal needles manufacturers
  • Spinal needles suppliers
  • Research and Development (R&D) companies
  • Independent research laboratories
  • Market research and consulting service providers
  • Medical research laboratories
  • Academic medical institutes and universities
Segmentation
Global spinal needle market is segmented on the basis of type, application and end users.  On the basis of type, the market is segmented into atraumatic needle tips, directional spinal needles, pencil-point needles and others. On the basis of size, the market is segmented into 24G, 25G, 27G and other. On the basis of application, the market is segmented into diagnostic and therapeutic. And on the basis of end users, they are segmented into hospitals, clinics and other.
Browse Complete 80 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/spinal-needles-market-1216


About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Subscribe to: Posts (Atom)